text: KI-BN

text: public

text: NCAP-SELEX__ligand-lig200__TF-ZNF821__cycle-1__batch-FJ46__well-K22

text: synthetic construct

text: synthetic construct


status: PUBLIC

tag: attribute

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: KI-BN

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: NCAP-SELEX__ligand-lig200__TF-ZNF821__cycle-2__batch-FJ46__well-K22

characteristic: Submitter Id

text: synthetic construct

characteristic: organism

text: synthetic construct

characteristic: title


text: KI-BN

text: public

text: NCAP-SELEX__ligand-lig200__TF-ZNF821__cycle-3__batch-FJ46__well-K22

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: NCAP-SELEX__ligand-lig200__TF-ZNF821__cycle-4__batch-FJ46__well-K22

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: synthetic construct

text: synthetic construct


text: public

tag: Namespace:MAX PLANCK INSTITUTE FOR MARINE MICROBIOLOGY

characteristic: collection date

text: Marine sediment ciliate Kentrophoros sp. H and associated bacteria, sample SA332. Single ciliate cell fixed for DNA/RNA sequencing.

characteristic: description

text: marine neritic benthic zone biome

characteristic: environment (biome)

text: sea grass bed

characteristic: environment (feature)

text: shallow marine sediment

characteristic: environment (material)

text: Italy

characteristic: geographic location (country and/or sea)

unit: m

characteristic: geographic location (depth)

unit: DD

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Isola d'Elba; Sant' Andrea

characteristic: geographic location (region and locality)

text: Kentrophoros sp. H

characteristic: host common name

characteristic: host taxid

text: host-associated

characteristic: host-associated environmental package

text: metagenome

characteristic: investigation type

text: ciliate metagenome

text: Metagenomics and metatranscriptomics of marine ciliates Kentrophoros spp. and their symbiotic bacteria

characteristic: project name

text: decantation after stirring with seawater

characteristic: sample collection device or method

text: fixed in RNAlater

characteristic: sample material processing

text: ciliate metagenome

text: Illumina

characteristic: sequencing method

text: Kentrophoros sp. H sample SA332


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: MAX PLANCK INSTITUTE FOR MARINE MICROBIOLOGY

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: collection date

text: Marine sediment ciliate Kentrophoros sp. H and associated bacteria, sample SA331. Single ciliate cell fixed for DNA/RNA sequencing.

characteristic: description

text: marine neritic benthic zone biome

text: sea grass bed

text: shallow marine sediment

text: Italy

text: Isola d'Elba; Sant' Andrea

text: Kentrophoros sp. H

text: host-associated

text: metagenome

text: ciliate metagenome

characteristic: organism

text: fixed in RNAlater

text: ciliate metagenome

text: Illumina

text: Kentrophoros sp. H sample SA331

characteristic: title


text: public

text: Marine sediment ciliate Kentrophoros sp. H and associated bacteria, sample SA333. Single ciliate cell fixed for DNA/RNA sequencing.

text: marine neritic benthic zone biome

characteristic: environment (biome)

text: sea grass bed

characteristic: environment (feature)

text: shallow marine sediment

characteristic: environment (material)

text: Italy

characteristic: geographic location (country and/or sea)

characteristic: geographic location (depth)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Isola d'Elba; Sant' Andrea

characteristic: geographic location (region and locality)

text: Kentrophoros sp. H

characteristic: host common name

characteristic: host taxid

text: host-associated

characteristic: host-associated environmental package

text: metagenome

characteristic: investigation type

text: ciliate metagenome

characteristic: project name

characteristic: sample collection device or method

text: fixed in RNAlater

text: ciliate metagenome

text: Illumina

text: Kentrophoros sp. H sample SA333


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: collection date

text: Marine sediment ciliate Kentrophoros sp. SD and associated bacteria, sample S4111. Single ciliate cell fixed for DNA/RNA sequencing.

characteristic: description

text: marine neritic benthic zone biome

text: bay

text: shallow marine sediment

text: Italy

text: Isola d'Elba; Golfo di Barbatoia

text: Kentrophoros sp. SD

text: host-associated

text: metagenome

text: ciliate metagenome

text: Uhlig seawater ice method

text: fixed in RNAlater

characteristic: sample material processing

text: ciliate metagenome

text: Illumina

characteristic: sequencing method

text: Kentrophoros sp. SD sample S4111


text: public

text: Marine sediment ciliate Kentrophoros sp. SD and associated bacteria, sample S4112. Single ciliate cell fixed for DNA/RNA sequencing.

text: marine neritic benthic zone biome

characteristic: environment (biome)

text: bay

characteristic: environment (feature)

text: shallow marine sediment

characteristic: environment (material)

text: Italy

characteristic: geographic location (country and/or sea)

characteristic: geographic location (depth)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Isola d'Elba; Golfo di Barbatoia

characteristic: geographic location (region and locality)

text: Kentrophoros sp. SD

characteristic: host common name

characteristic: host taxid

text: host-associated

characteristic: host-associated environmental package

text: metagenome

characteristic: investigation type

text: ciliate metagenome

characteristic: organism

text: Uhlig seawater ice method

text: fixed in RNAlater

text: ciliate metagenome

text: Illumina

text: Kentrophoros sp. SD sample S4112

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: collection date

text: Marine sediment ciliate Kentrophoros sp. SD and associated bacteria, sample S4110. Single ciliate cell fixed for DNA/RNA sequencing.

characteristic: description

text: marine neritic benthic zone biome

text: bay

text: shallow marine sediment

text: Italy

text: Isola d'Elba; Golfo di Barbatoia

text: Kentrophoros sp. SD

text: host-associated

text: metagenome

text: ciliate metagenome

characteristic: project name

text: Uhlig seawater ice method

characteristic: sample collection device or method

text: fixed in RNAlater

text: ciliate metagenome

text: Illumina

text: Kentrophoros sp. SD sample S4110


text: Saccharomyces cerevisiae

characteristic: ArrayExpress-SPECIES

text: SC

text: public

text: baker's yeast

characteristic: common name

text: Saccharomyces cerevisiae

text: Saccharomyces cerevisiae

characteristic: subject id


characteristic: ENA-CHECKLIST

text: public

tag: Namespace:NATIONAL INSTITUTE FOR HEALTH AND WELFARE

text: Mycobacterium tuberculosis

characteristic: organism

text: Mycobacterium tuberculosis

text: TB WGS

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: NATIONAL INSTITUTE FOR HEALTH AND WELFARE

text: public

text: Mycobacterium tuberculosis

text: Mycobacterium tuberculosis

text: TB WGS


text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

tag: Namespace:Quadram Institute Bioscience

unit: year

characteristic: age

text: body mass index at start 26.8

unit: kilogram per square meter

characteristic: body mass index

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 12.6

unit: nanogram per milliliter

characteristic: clinical information

text: human

text: Protocols: Forty-nine men with a clinical diagnosis of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. All patients had an American Society of Anaesthesiologists (ASA) co-morbidity score of 1 or 2, which reflects the health status of men eligible for active surveillance. Of the 25-35 cores obtained each at T0 and T12, three were reserved for next generation sequencing (NGS), three were used for targeted and non-targeted metabolite analyses, two were snap frozen and the remainder underwent routine histopathological examination. ESCAPE study design. The ESCAPE study involved the recruitment of 49 men with of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. The protocol was approved by the Quadram Institute Bioscience Human Research Governance Committee and subsequently by the National Research Ethics Service (NRES) East of England - Cambridge South Research Ethics Committee (REC ref: 13/EE/0110). ESCAPE has been adopted on the National Institute for Health Research Clinical Research Network (NIHR) Clinical Research Network (CRN) Portfolio in May 2013 (Study ID: 14482). The trial has been registered on ClinicalTrials.gov (NCT01950143), (ii) International Clinical Trials Registry Platform (ISRCTN40496794), and (iii) Clinical Trials database Cancer Research UK (http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-effect-sulforaphaneprostate-cancer-escape. Immediately prior to the study, the volunteers completed a comprehensive seven-day diet diary to assess their habitual diet. During the 12-month interval, the volunteers consumed their habitual diet supplemented with one 300 ml portion of a broccoli-based soup per week. The soups were otherwise identical but were manufactured from one of three broccoli Myb28 genotypes, delivering a mean ± standard deviation for standard broccoli soup of 8.4 ± 2.8, beneforte soup of 280 ± 8.8 and beneforte extra soup of 452 ± 10.6 µmoles glucoraphanin per 300 ml portion. Further diet diaries were completed at six and twelve months. Diet data from both habitual diet and the additional soups were integrated and analysed through DietPlan6 combined with additional data on chemical composition of cruciferous and alliaceous vegetables obtained from analyses of vegetables purchased in the retail outlets in the localities of the volunteers. Disease staging refers to WHO grade for prostate carcinoma. Two cores per patient weighing between 3 and 10 mg in total were homogenised with a QIAGEN TissueRuptor before total RNA was extracted with the QIAGEN RNeasy Mini kit. The resulting RNA was quality checked with an Agilent Bioanalyzer and samples with RIN values higher than 7 were further processed. Samples were subjected to ribodepletion with the Ribo-Zero Magnetic Gold rRNA Removal Kit (Illumina). Libraries were constructed with the Illumina barcoded TruSeq kit.

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 31.2

text: ArrayExpress

text: prostate specific antigen measurement 9.8

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 25.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 5.9

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 30.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 10.9

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 29.1

text: ArrayExpress

text: prostate specific antigen measurement 5.6

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 29.9

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 19.9

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 25.6

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 7.8

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 23.9

text: ArrayExpress

text: prostate specific antigen measurement 15.1

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 21.9

characteristic: body mass index

text: ArrayExpress

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 22.8

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 8.4

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.6

text: ArrayExpress

text: prostate specific antigen measurement 4.5

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 23.4

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 1.9

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 28.1

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 9

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 19.4

text: ArrayExpress

text: prostate specific antigen measurement 3.3

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 23.6

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 7.6

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 25.7

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 8.6

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.2

text: ArrayExpress

text: prostate specific antigen measurement 2.9

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.8

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 9.3

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 30.8

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 9.4

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 33.6

text: ArrayExpress

text: prostate specific antigen measurement 15.3

text: human

characteristic: common name

text: Protocols: Forty-nine men with a clinical diagnosis of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. All patients had an American Society of Anaesthesiologists (ASA) co-morbidity score of 1 or 2, which reflects the health status of men eligible for active surveillance. Of the 25-35 cores obtained each at T0 and T12, three were reserved for next generation sequencing (NGS), three were used for targeted and non-targeted metabolite analyses, two were snap frozen and the remainder underwent routine histopathological examination. ESCAPE study design. The ESCAPE study involved the recruitment of 49 men with of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. The protocol was approved by the Quadram Institute Bioscience Human Research Governance Committee and subsequently by the National Research Ethics Service (NRES) East of England - Cambridge South Research Ethics Committee (REC ref: 13/EE/0110). ESCAPE has been adopted on the National Institute for Health Research Clinical Research Network (NIHR) Clinical Research Network (CRN) Portfolio in May 2013 (Study ID: 14482). The trial has been registered on ClinicalTrials.gov (NCT01950143), (ii) International Clinical Trials Registry Platform (ISRCTN40496794), and (iii) Clinical Trials database Cancer Research UK (http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-effect-sulforaphaneprostate-cancer-escape. Immediately prior to the study, the volunteers completed a comprehensive seven-day diet diary to assess their habitual diet. During the 12-month interval, the volunteers consumed their habitual diet supplemented with one 300 ml portion of a broccoli-based soup per week. The soups were otherwise identical but were manufactured from one of three broccoli Myb28 genotypes, delivering a mean ± standard deviation for standard broccoli soup of 8.4 ± 2.8, beneforte soup of 280 ± 8.8 and beneforte extra soup of 452 ± 10.6 µmoles glucoraphanin per 300 ml portion. Further diet diaries were completed at six and twelve months. Diet data from both habitual diet and the additional soups were integrated and analysed through DietPlan6 combined with additional data on chemical composition of cruciferous and alliaceous vegetables obtained from analyses of vegetables purchased in the retail outlets in the localities of the volunteers. Disease staging refers to WHO grade for prostate carcinoma. Two cores per patient weighing between 3 and 10 mg in total were homogenised with a QIAGEN TissueRuptor before total RNA was extracted with the QIAGEN RNeasy Mini kit. The resulting RNA was quality checked with an Agilent Bioanalyzer and samples with RIN values higher than 7 were further processed. Samples were subjected to ribodepletion with the Ribo-Zero Magnetic Gold rRNA Removal Kit (Illumina). Libraries were constructed with the Illumina barcoded TruSeq kit.

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.7

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 4.3

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 27

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 6.7

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 31.1

text: ArrayExpress

text: prostate specific antigen measurement 6.5

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 26.1

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 10.3

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 30.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 8.8

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 23.6

text: ArrayExpress

text: prostate specific antigen measurement 12.8

text: human

characteristic: common name

text: Protocols: This volunteer withdrew from the study and opted for prostatectomy at the end of the study. Therefore the 12 months prostate biopsy came from the prostate at the time of prostatectomy (rather than through transperineal template biosy). ESCAPE study design. The ESCAPE study involved the recruitment of 49 men with of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. The protocol was approved by the Quadram Institute Bioscience Human Research Governance Committee and subsequently by the National Research Ethics Service (NRES) East of England - Cambridge South Research Ethics Committee (REC ref: 13/EE/0110). ESCAPE has been adopted on the National Institute for Health Research Clinical Research Network (NIHR) Clinical Research Network (CRN) Portfolio in May 2013 (Study ID: 14482). The trial has been registered on ClinicalTrials.gov (NCT01950143), (ii) International Clinical Trials Registry Platform (ISRCTN40496794), and (iii) Clinical Trials database Cancer Research UK (http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-effect-sulforaphaneprostate-cancer-escape. Immediately prior to the study, the volunteers completed a comprehensive seven-day diet diary to assess their habitual diet. During the 12-month interval, the volunteers consumed their habitual diet supplemented with one 300 ml portion of a broccoli-based soup per week. The soups were otherwise identical but were manufactured from one of three broccoli Myb28 genotypes, delivering a mean ± standard deviation for standard broccoli soup of 8.4 ± 2.8, beneforte soup of 280 ± 8.8 and beneforte extra soup of 452 ± 10.6 µmoles glucoraphanin per 300 ml portion. Further diet diaries were completed at six and twelve months. Diet data from both habitual diet and the additional soups were integrated and analysed through DietPlan6 combined with additional data on chemical composition of cruciferous and alliaceous vegetables obtained from analyses of vegetables purchased in the retail outlets in the localities of the volunteers. Disease staging refers to WHO grade for prostate carcinoma. Two cores per patient weighing between 3 and 10 mg in total were homogenised with a QIAGEN TissueRuptor before total RNA was extracted with the QIAGEN RNeasy Mini kit. The resulting RNA was quality checked with an Agilent Bioanalyzer and samples with RIN values higher than 7 were further processed. Samples were subjected to ribodepletion with the Ribo-Zero Magnetic Gold rRNA Removal Kit (Illumina). Libraries were constructed with the Illumina barcoded TruSeq kit.

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 28.1

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 7.5

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 28.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 5.6

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 29.8

text: ArrayExpress

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 5.1

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 26.5

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 12

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.7

text: ArrayExpress

text: prostate specific antigen measurement 8.5

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 26.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 7.9

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 24.8

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 7.8

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.3

text: ArrayExpress

text: prostate specific antigen measurement 6.8

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.5

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 7.2

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 28.1

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 5.9

characteristic: clinical information

text: human

text: Protocols: Forty-nine men with a clinical diagnosis of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. All patients had an American Society of Anaesthesiologists (ASA) co-morbidity score of 1 or 2, which reflects the health status of men eligible for active surveillance. Of the 25-35 cores obtained each at T0 and T12, three were reserved for next generation sequencing (NGS), three were used for targeted and non-targeted metabolite analyses, two were snap frozen and the remainder underwent routine histopathological examination. ESCAPE study design. The ESCAPE study involved the recruitment of 49 men with of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. The protocol was approved by the Quadram Institute Bioscience Human Research Governance Committee and subsequently by the National Research Ethics Service (NRES) East of England - Cambridge South Research Ethics Committee (REC ref: 13/EE/0110). ESCAPE has been adopted on the National Institute for Health Research Clinical Research Network (NIHR) Clinical Research Network (CRN) Portfolio in May 2013 (Study ID: 14482). The trial has been registered on ClinicalTrials.gov (NCT01950143), (ii) International Clinical Trials Registry Platform (ISRCTN40496794), and (iii) Clinical Trials database Cancer Research UK (http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-effect-sulforaphaneprostate-cancer-escape. Immediately prior to the study, the volunteers completed a comprehensive seven-day diet diary to assess their habitual diet. During the 12-month interval, the volunteers consumed their habitual diet supplemented with one 300 ml portion of a broccoli-based soup per week. The soups were otherwise identical but were manufactured from one of three broccoli Myb28 genotypes, delivering a mean ± standard deviation for standard broccoli soup of 8.4 ± 2.8, beneforte soup of 280 ± 8.8 and beneforte extra soup of 452 ± 10.6 µmoles glucoraphanin per 300 ml portion. Further diet diaries were completed at six and twelve months. Diet data from both habitual diet and the additional soups were integrated and analysed through DietPlan6 combined with additional data on chemical composition of cruciferous and alliaceous vegetables obtained from analyses of vegetables purchased in the retail outlets in the localities of the volunteers. Disease staging refers to WHO grade for prostate carcinoma. Two cores per patient weighing between 3 and 10 mg in total were homogenised with a QIAGEN TissueRuptor before total RNA was extracted with the QIAGEN RNeasy Mini kit. The resulting RNA was quality checked with an Agilent Bioanalyzer and samples with RIN values higher than 7 were further processed. Samples were subjected to ribodepletion with the Ribo-Zero Magnetic Gold rRNA Removal Kit (Illumina). Libraries were constructed with the Illumina barcoded TruSeq kit.

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 25.3

text: ArrayExpress

text: prostate specific antigen measurement 11.6

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.8

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 6.3

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 28.1

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 7.7

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 25.4

text: ArrayExpress

text: prostate specific antigen measurement not available

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 26.5

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 17.4

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 33.9

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 4.2

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 26.8

text: ArrayExpress

text: prostate specific antigen measurement 10.4

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 31.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 12.3

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 29.1

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 7

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 31.9

text: ArrayExpress

text: prostate specific antigen measurement 12.6

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 29.7

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 12

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 23.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 7

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 25.2

text: ArrayExpress

text: prostate specific antigen measurement 8.3

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: not available

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 30.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 8.7

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 29.9

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 9.9

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 25.6

text: ArrayExpress

text: prostate specific antigen measurement 7.3

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: not available

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 23.9

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 13

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 21.9

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 10.5

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 22.8

text: ArrayExpress

text: prostate specific antigen measurement 6.6

text: human

characteristic: common name

text: Protocols: Forty-nine men with a clinical diagnosis of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. All patients had an American Society of Anaesthesiologists (ASA) co-morbidity score of 1 or 2, which reflects the health status of men eligible for active surveillance. Of the 25-35 cores obtained each at T0 and T12, three were reserved for next generation sequencing (NGS), three were used for targeted and non-targeted metabolite analyses, two were snap frozen and the remainder underwent routine histopathological examination. ESCAPE study design. The ESCAPE study involved the recruitment of 49 men with of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. The protocol was approved by the Quadram Institute Bioscience Human Research Governance Committee and subsequently by the National Research Ethics Service (NRES) East of England - Cambridge South Research Ethics Committee (REC ref: 13/EE/0110). ESCAPE has been adopted on the National Institute for Health Research Clinical Research Network (NIHR) Clinical Research Network (CRN) Portfolio in May 2013 (Study ID: 14482). The trial has been registered on ClinicalTrials.gov (NCT01950143), (ii) International Clinical Trials Registry Platform (ISRCTN40496794), and (iii) Clinical Trials database Cancer Research UK (http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-effect-sulforaphaneprostate-cancer-escape. Immediately prior to the study, the volunteers completed a comprehensive seven-day diet diary to assess their habitual diet. During the 12-month interval, the volunteers consumed their habitual diet supplemented with one 300 ml portion of a broccoli-based soup per week. The soups were otherwise identical but were manufactured from one of three broccoli Myb28 genotypes, delivering a mean ± standard deviation for standard broccoli soup of 8.4 ± 2.8, beneforte soup of 280 ± 8.8 and beneforte extra soup of 452 ± 10.6 µmoles glucoraphanin per 300 ml portion. Further diet diaries were completed at six and twelve months. Diet data from both habitual diet and the additional soups were integrated and analysed through DietPlan6 combined with additional data on chemical composition of cruciferous and alliaceous vegetables obtained from analyses of vegetables purchased in the retail outlets in the localities of the volunteers. Disease staging refers to WHO grade for prostate carcinoma. Two cores per patient weighing between 3 and 10 mg in total were homogenised with a QIAGEN TissueRuptor before total RNA was extracted with the QIAGEN RNeasy Mini kit. The resulting RNA was quality checked with an Agilent Bioanalyzer and samples with RIN values higher than 7 were further processed. Samples were subjected to ribodepletion with the Ribo-Zero Magnetic Gold rRNA Removal Kit (Illumina). Libraries were constructed with the Illumina barcoded TruSeq kit.

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 29.8

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 7

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 26.5

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 10.7

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 24.6

text: ArrayExpress

text: prostate specific antigen measurement 5.7

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 28.3

characteristic: body mass index

text: ArrayExpress

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 27.8

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 5.8

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 29.9

text: ArrayExpress

text: prostate specific antigen measurement 14.1

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 31.9

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 8.9

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 23.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 4.2

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 29.7

text: ArrayExpress

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 5.6

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 26.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 9.8

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.7

text: ArrayExpress

text: prostate specific antigen measurement 7.2

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 28.6

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 4.8

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 23.4

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 3

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.1

text: ArrayExpress

text: prostate specific antigen measurement 6.1

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 24.8

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 5

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 19.4

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 3.3

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 23.6

text: ArrayExpress

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 25.7

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 9.3

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 28.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 1.6

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 30.8

text: ArrayExpress

text: prostate specific antigen measurement 6.7

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 33.6

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 13.9

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 24.6

text: ArrayExpress

characteristic: broker name

characteristic: clinical information

text: human

text: Protocols: Forty-nine men with a clinical diagnosis of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. All patients had an American Society of Anaesthesiologists (ASA) co-morbidity score of 1 or 2, which reflects the health status of men eligible for active surveillance. Of the 25-35 cores obtained each at T0 and T12, three were reserved for next generation sequencing (NGS), three were used for targeted and non-targeted metabolite analyses, two were snap frozen and the remainder underwent routine histopathological examination. ESCAPE study design. The ESCAPE study involved the recruitment of 49 men with of low- or intermediate-risk organ-confined prostate cancer underwent two transperineal template biopsy procedures at 12-month intervals. The protocol was approved by the Quadram Institute Bioscience Human Research Governance Committee and subsequently by the National Research Ethics Service (NRES) East of England - Cambridge South Research Ethics Committee (REC ref: 13/EE/0110). ESCAPE has been adopted on the National Institute for Health Research Clinical Research Network (NIHR) Clinical Research Network (CRN) Portfolio in May 2013 (Study ID: 14482). The trial has been registered on ClinicalTrials.gov (NCT01950143), (ii) International Clinical Trials Registry Platform (ISRCTN40496794), and (iii) Clinical Trials database Cancer Research UK (http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-effect-sulforaphaneprostate-cancer-escape. Immediately prior to the study, the volunteers completed a comprehensive seven-day diet diary to assess their habitual diet. During the 12-month interval, the volunteers consumed their habitual diet supplemented with one 300 ml portion of a broccoli-based soup per week. The soups were otherwise identical but were manufactured from one of three broccoli Myb28 genotypes, delivering a mean ± standard deviation for standard broccoli soup of 8.4 ± 2.8, beneforte soup of 280 ± 8.8 and beneforte extra soup of 452 ± 10.6 µmoles glucoraphanin per 300 ml portion. Further diet diaries were completed at six and twelve months. Diet data from both habitual diet and the additional soups were integrated and analysed through DietPlan6 combined with additional data on chemical composition of cruciferous and alliaceous vegetables obtained from analyses of vegetables purchased in the retail outlets in the localities of the volunteers. Disease staging refers to WHO grade for prostate carcinoma. Two cores per patient weighing between 3 and 10 mg in total were homogenised with a QIAGEN TissueRuptor before total RNA was extracted with the QIAGEN RNeasy Mini kit. The resulting RNA was quality checked with an Agilent Bioanalyzer and samples with RIN values higher than 7 were further processed. Samples were subjected to ribodepletion with the Ribo-Zero Magnetic Gold rRNA Removal Kit (Illumina). Libraries were constructed with the Illumina barcoded TruSeq kit.

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.3

text: ArrayExpress

text: prostate specific antigen measurement 10.8

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27.8

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 4.4

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 27.7

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 4.1

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 29.9

text: ArrayExpress

text: prostate specific antigen measurement 10.7

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 27

characteristic: body mass index

text: ArrayExpress

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 31.1

text: ArrayExpress

characteristic: broker name

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 26.1

text: ArrayExpress

text: prostate specific antigen measurement 7.6

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 30.2

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 11.4

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 23.6

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 11.1

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.3

text: ArrayExpress

text: prostate specific antigen measurement 5.2

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: not available

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 28.1

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 6.6

text: human

text: prostate carcinoma

text: not available

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 28.2

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 4.3

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

text: not available

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 27.5

text: ArrayExpress

text: prostate specific antigen measurement 5.1

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 28.1

characteristic: body mass index

text: ArrayExpress

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 25.3

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 9.2

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 28.1

text: ArrayExpress

text: prostate specific antigen measurement 7.3

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: not available

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Quadram Institute Bioscience

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: age

text: body mass index at start 25.4

characteristic: body mass index

text: ArrayExpress

text: prostate specific antigen measurement 5.3

text: human

text: prostate carcinoma

text: Homo sapiens

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male


text: Quadram Institute Bioscience

text: public

text: body mass index at start 26.5

text: ArrayExpress

characteristic: broker name

text: prostate specific antigen measurement 10.9

characteristic: clinical information

text: human

text: prostate carcinoma

characteristic: disease

characteristic: disease staging

characteristic: individual

text: Homo sapiens

text: Homo sapiens

text: prostate

characteristic: organism part

text: Homo sapiens

text: male

characteristic: sex

characteristic: studycode


characteristic: ENA-CHECKLIST

text: Quadram Institute Bioscience

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: body mass index at start 33.9

text: ArrayExpress

text: human

characteristic: common name

characteristic: description

text: prostate carcinoma

text: Homo sapiens

characteristic: organism

text: Homo sapiens

text: prostate

text: Homo sapiens

text: male

characteristic: title


characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: KI-BN

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-FOXA2__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-FOXA2__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-FOXA2__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-FOXA2__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-FOXA2__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-FOXA2__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-IRF8__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-IRF8__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-IRF8__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-IRF8__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-IRF8__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-IRF8__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-SOX10__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-SOX10__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-SOX10__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-SOX10__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-SOX10__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-SOX10__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX21__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX21__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX21__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX21__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX21__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX21__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX3__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX3__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX3__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX3__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX3__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX3__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX4__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX4__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX4__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX4__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX4__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TBX4__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TFAP2B__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TFAP2B__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TFAP2B__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TFAP2B__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TFAP2B__cycle-5__bound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig147__TF-TFAP2B__cycle-5__unbound-TFpresent

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-FOXA2__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-FOXA2__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-FOXA2__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-FOXA2__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF7__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF7__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF7__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF7__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF8__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF8__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF8__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-IRF8__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-SOX10__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-SOX10__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-SOX10__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-SOX10__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX21__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX21__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX21__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX21__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX3__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX3__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX3__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX3__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX4__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX4__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX4__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TBX4__cycle-4

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TFAP2B__cycle-1

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TFAP2B__cycle-2

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TFAP2B__cycle-3

text: synthetic construct

text: synthetic construct


text: KI-BN

text: public

text: Doubled_TFconc__NCAP-SELEX__ligand-lig200__TF-TFAP2B__cycle-4

text: synthetic construct

text: synthetic construct


text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

text: public

tag: Namespace:CANCER RESEARCH UK CAMBRIDGE INSTITUTE

text: southeastern Asian house mouse

characteristic: date of birth

characteristic: date of death

text: liver dysplastic nodule 91864_N3 from DEN treated individual 91864. This sample is a unique specimen from this individual.

text: dysplastic nodule

characteristic: diagnosis

characteristic: individual name

text: Mus musculus castaneus

characteristic: sample name

text: Mus musculus castaneus

text: male

text: CAST/EiJ

characteristic: strain

text: liver

characteristic: tissue type

text: DEN

characteristic: treatment agent

characteristic: treatment date

unit: ug/g body weight

characteristic: treatment dose

text: high

characteristic: tumour grading


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: southeastern Asian house mouse

characteristic: common name

text: liver dysplastic nodule 91424_N2 from DEN treated individual 91424. This sample is a unique specimen from this individual.

characteristic: description

text: dysplastic nodule

text: Mus musculus castaneus

characteristic: organism

text: Mus musculus castaneus

text: male

characteristic: sex

text: CAST/EiJ

text: liver

characteristic: title

text: DEN

text: low


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

text: southeastern Asian house mouse

characteristic: date of birth

characteristic: date of death

text: liver dysplastic nodule 91868_N2 from DEN treated individual 91868. This sample is a unique specimen from this individual.

text: dysplastic nodule

characteristic: diagnosis

characteristic: individual name

text: Mus musculus castaneus

characteristic: sample name

text: Mus musculus castaneus

text: male

text: CAST/EiJ

text: liver

text: DEN

text: high


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

text: public

characteristic: INSDC status

characteristic: SRA accession

text: southeastern Asian house mouse

text: liver dysplastic nodule 90068_N2 from DEN treated individual 90068. This sample is a unique specimen from this individual.

text: dysplastic nodule

text: Mus musculus castaneus

text: Mus musculus castaneus

text: male

text: CAST/EiJ

characteristic: strain

text: liver

characteristic: tissue type

text: DEN

characteristic: treatment agent

characteristic: treatment date

characteristic: treatment dose

text: low

characteristic: tumour grading


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: Submitter Id

text: southeastern Asian house mouse

characteristic: common name

text: liver dysplastic nodule 91121_N4 from DEN treated individual 91121. This sample is a unique specimen from this individual.

characteristic: description

text: dysplastic nodule

text: Mus musculus castaneus

characteristic: organism

text: Mus musculus castaneus

text: male

characteristic: sex

text: CAST/EiJ

text: liver

characteristic: title

text: DEN

text: low


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: southeastern Asian house mouse

characteristic: date of birth

characteristic: date of death

text: liver dysplastic nodule 88305_N2 from DEN treated individual 88305. This sample is a unique specimen from this individual.

text: dysplastic nodule

characteristic: diagnosis

characteristic: individual name

text: Mus musculus castaneus

characteristic: sample name

text: Mus musculus castaneus

text: male

text: CAST/EiJ

text: liver

text: DEN

text: high


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: southeastern Asian house mouse

text: liver dysplastic nodule 91121_N2 from DEN treated individual 91121. This sample is a unique specimen from this individual.

text: dysplastic nodule

text: Mus musculus castaneus

text: Mus musculus castaneus

text: male

text: CAST/EiJ

characteristic: strain

text: liver

characteristic: tissue type

text: DEN

characteristic: treatment agent

characteristic: treatment date

characteristic: treatment dose

text: high

characteristic: tumour grading


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: Submitter Id

text: southeastern Asian house mouse

characteristic: common name

text: liver dysplastic nodule 90590_N1 from DEN treated individual 90590. This sample is a unique specimen from this individual.

characteristic: description

text: dysplastic nodule

text: Mus musculus castaneus

characteristic: organism

text: Mus musculus castaneus

text: male

characteristic: sex

text: CAST/EiJ

text: liver

characteristic: title

text: DEN

text: high


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: SRA accession

text: southeastern Asian house mouse

characteristic: date of birth

characteristic: date of death

text: liver dysplastic nodule 91430_N3 from DEN treated individual 91430. This sample is a unique specimen from this individual.

text: dysplastic nodule

characteristic: diagnosis

characteristic: individual name

text: Mus musculus castaneus

characteristic: sample name

text: Mus musculus castaneus

text: male

text: CAST/EiJ

text: liver

text: DEN

text: high


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: house mouse

text: liver dysplastic nodule 92105_N3 from DEN treated individual 92105. This sample is a unique specimen from this individual.

text: dysplastic nodule

text: Mus musculus

text: Mus musculus

text: male

characteristic: strain

text: liver

characteristic: tissue type

text: DEN

characteristic: treatment agent

characteristic: treatment date

characteristic: treatment dose

text: high

characteristic: tumour grading


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: Submitter Id

text: southeastern Asian house mouse

characteristic: common name

text: liver dysplastic nodule 91867_N1 from DEN treated individual 91867. This sample is a unique specimen from this individual.

characteristic: description

text: dysplastic nodule

text: Mus musculus castaneus

characteristic: organism

text: Mus musculus castaneus

text: male

characteristic: sex

text: CAST/EiJ

text: liver

characteristic: title

text: DEN

text: low


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: southeastern Asian house mouse

characteristic: date of birth

characteristic: date of death

text: liver dysplastic nodule 91424_N1 from DEN treated individual 91424. This sample is a unique specimen from this individual.

text: dysplastic nodule

characteristic: diagnosis

characteristic: individual name

text: Mus musculus castaneus

characteristic: sample name

text: Mus musculus castaneus

text: male

text: CAST/EiJ

text: liver

text: DEN

text: high


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: southeastern Asian house mouse

text: liver dysplastic nodule 91589_N1 from DEN treated individual 91589. This sample is a unique specimen from this individual.

text: dysplastic nodule

text: Mus musculus castaneus

text: Mus musculus castaneus

text: male

text: CAST/EiJ

characteristic: strain

text: liver

characteristic: tissue type

text: DEN

characteristic: treatment agent

characteristic: treatment date

characteristic: treatment dose

text: high

characteristic: tumour grading


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: Submitter Id

text: southeastern Asian house mouse

characteristic: common name

text: liver dysplastic nodule 89489_N6 from DEN treated individual 89489. This sample is a unique specimen from this individual.

characteristic: description

text: dysplastic nodule

text: Mus musculus castaneus

characteristic: organism

text: Mus musculus castaneus

text: male

characteristic: sex

text: CAST/EiJ

text: liver

characteristic: title

text: DEN

text: high


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: CANCER RESEARCH UK CAMBRIDGE INSTITUTE

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: SRA accession

text: southeastern Asian house mouse

characteristic: date of birth

characteristic: date of death

text: liver dysplastic nodule 91520_N2 from DEN treated individual 91520. This sample is a unique specimen from this individual.

text: dysplastic nodule

characteristic: diagnosis

characteristic: individual name

text: Mus musculus castaneus

characteristic: sample name

text: Mus musculus castaneus

text: male

text: CAST/EiJ

text: liver

text: DEN

text: high